Golden State Equity Partners »

BioCryst Pharmaceuticals shares owned by Golden State Equity Partners

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Golden State Equity Partners from 13F filings

Historical chart of Golden State Equity Partners investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Golden State Equity Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Golden State Equity Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $69k 11k 5.99
2023-09-30 $77k 11k 7.08
2023-06-30 $77k 11k 7.04
2023-03-31 $91k 11k 8.34
2022-03-31 $186k 11k 16.27
2021-12-31 $158k 11k 13.82

More positions owned by Golden State Equity Partners

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
salesforce (CRM)
First Tr Mid Cap Core Alphad Com Shs (FNX)
JPMorgan Chase & Co. (JPM)
Hartford Fds Exchange Traded Total Rtrn Etf (HTRB)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Spdr Ser Tr Portfolio S&p500 (SPLG)
First Tr Exch Traded Fd Iii Horizon Mngd Etf (HDMV)
First Tr Exch Traded Fd Iii Horizon Dmst Etf (HUSV)

View all positions for Golden State Equity Partners

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Kynam Capital Management
Deerfield Management Company
Geode Capital Management
RP Management
Rock Springs Capital Management
Jennifer Ranahan
Braidwell
Fisher Investments
Nuveen Asset Management
Two Sigma Advisers
Ameriprise Financial

View all funds holding BioCryst Pharmaceuticals